Literature DB >> 25753752

Characterization of the p300 Taz2-p53 TAD2 complex and comparison with the p300 Taz2-p53 TAD1 complex.

Lisa M Miller Jenkins1, Hanqiao Feng2, Stewart R Durell1, Harichandra D Tagad1, Sharlyn J Mazur1, Joseph E Tropea3, Yawen Bai2, Ettore Appella1.   

Abstract

The p53 tumor suppressor is a critical mediator of the cellular response to stress. The N-terminal transactivation domain of p53 makes protein interactions that promote its function as a transcription factor. Among those cofactors is the histone acetyltransferase p300, which both stabilizes p53 and promotes local chromatin unwinding. Here, we report the nuclear magnetic resonance solution structure of the Taz2 domain of p300 bound to the second transactivation subdomain of p53. In the complex, p53 forms an α-helix between residues 47 and 55 that interacts with the α1-α2-α3 face of Taz2. Mutational analysis indicated several residues in both p53 and Taz2 that are critical for stabilizing the interaction. Finally, further characterization of the complex by isothermal titration calorimetry revealed that complex formation is pH-dependent and releases a bound chloride ion. This study highlights differences in the structures of complexes formed by the two transactivation subdomains of p53 that may be broadly observed and play critical roles in p53 transcriptional activity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25753752      PMCID: PMC7722985          DOI: 10.1021/acs.biochem.5b00044

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  57 in total

1.  A novel target recognition revealed by calmodulin in complex with Ca2+-calmodulin-dependent kinase kinase.

Authors:  M Osawa; H Tokumitsu; M B Swindells; H Kurihara; M Orita; T Shibanuma; T Furuya; M Ikura
Journal:  Nat Struct Biol       Date:  1999-09

2.  Definition of the p53 functional domains necessary for inducing apoptosis.

Authors:  J Zhu; S Zhang; J Jiang; X Chen
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

3.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

Authors:  J Momand; G P Zambetti; D C Olson; D George; A J Levine
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

4.  An improved double-tuned and isotope-filtered pulse scheme based on a pulsed field gradient and a wide-band inversion shaped pulse.

Authors:  K Ogura; H Terasawa; F Inagaki
Journal:  J Biomol NMR       Date:  1996-12       Impact factor: 2.835

5.  Version 1.2 of the Crystallography and NMR system.

Authors:  Axel T Brunger
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

6.  Solution structure of Vps27 UIM-ubiquitin complex important for endosomal sorting and receptor downregulation.

Authors:  Kurt A Swanson; Richard S Kang; Svetoslava D Stamenova; Linda Hicke; Ishwar Radhakrishnan
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

7.  Two tandem and independent sub-activation domains in the amino terminus of p53 require the adaptor complex for activity.

Authors:  R Candau; D M Scolnick; P Darpino; C Y Ying; T D Halazonetis; S L Berger
Journal:  Oncogene       Date:  1997-08-14       Impact factor: 9.867

8.  Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression.

Authors:  Colleen A Brady; Dadi Jiang; Stephano S Mello; Thomas M Johnson; Lesley A Jarvis; Margaret M Kozak; Daniela Kenzelmann Broz; Shashwati Basak; Eunice J Park; Margaret E McLaughlin; Anthony N Karnezis; Laura D Attardi
Journal:  Cell       Date:  2011-05-13       Impact factor: 41.582

9.  Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain.

Authors:  P H Kussie; S Gorina; V Marechal; B Elenbaas; J Moreau; A J Levine; N P Pavletich
Journal:  Science       Date:  1996-11-08       Impact factor: 47.728

10.  Structural basis for recruitment of CBP/p300 coactivators by STAT1 and STAT2 transactivation domains.

Authors:  Jonathan M Wojciak; Maria A Martinez-Yamout; H Jane Dyson; Peter E Wright
Journal:  EMBO J       Date:  2009-02-12       Impact factor: 11.598

View more
  20 in total

1.  Long-range regulation of p53 DNA binding by its intrinsically disordered N-terminal transactivation domain.

Authors:  Alexander S Krois; H Jane Dyson; Peter E Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-12       Impact factor: 11.205

2.  Intracellular displacement of p53 using transactivation domain (p53 TAD) specific nanobodies.

Authors:  Anneleen Steels; Adriaan Verhelle; Olivier Zwaenepoel; Jan Gettemans
Journal:  MAbs       Date:  2018-09-11       Impact factor: 5.857

3.  A phosphorylation-dependent switch in the disordered p53 transactivation domain regulates DNA binding.

Authors:  Xun Sun; H Jane Dyson; Peter E Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-21       Impact factor: 11.205

Review 4.  Functional advantages of dynamic protein disorder.

Authors:  Rebecca B Berlow; H Jane Dyson; Peter E Wright
Journal:  FEBS Lett       Date:  2015-06-11       Impact factor: 4.124

Review 5.  Role of Intrinsic Protein Disorder in the Function and Interactions of the Transcriptional Coactivators CREB-binding Protein (CBP) and p300.

Authors:  H Jane Dyson; Peter E Wright
Journal:  J Biol Chem       Date:  2016-02-05       Impact factor: 5.157

6.  Characterization of the High-Affinity Fuzzy Complex between the Disordered Domain of the E7 Oncoprotein from High-Risk HPV and the TAZ2 Domain of CBP.

Authors:  Michael W Risør; Ariane L Jansma; Natasha Medici; Brittany Thomas; H Jane Dyson; Peter E Wright
Journal:  Biochemistry       Date:  2021-12-14       Impact factor: 3.162

7.  Structural insights into TAZ2 domain-mediated CBP/p300 recruitment by transactivation domain 1 of the lymphopoietic transcription factor E2A.

Authors:  Marina R Lochhead; Alexandra D Brown; Alyssa C Kirlin; Seth Chitayat; Kim Munro; Jane E Findlay; George S Baillie; David P LeBrun; David N Langelaan; Steven P Smith
Journal:  J Biol Chem       Date:  2020-02-25       Impact factor: 5.157

8.  Recognition of the disordered p53 transactivation domain by the transcriptional adapter zinc finger domains of CREB-binding protein.

Authors:  Alexander S Krois; Josephine C Ferreon; Maria A Martinez-Yamout; H Jane Dyson; Peter E Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-14       Impact factor: 11.205

9.  The oncoprotein HBXIP modulates the feedback loop of MDM2/p53 to enhance the growth of breast cancer.

Authors:  Hang Li; Qian Liu; Zhen Wang; Runping Fang; Yu Shen; Xiaoli Cai; Yuen Gao; Yinghui Li; Xiaodong Zhang; Lihong Ye
Journal:  J Biol Chem       Date:  2015-07-30       Impact factor: 5.157

10.  On the specificity of protein-protein interactions in the context of disorder.

Authors:  Kaare Teilum; Johan G Olsen; Birthe B Kragelund
Journal:  Biochem J       Date:  2021-06-11       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.